Chen Wan-Shan
Chen Wan-Shan, DIR, reported a transaction classified as exercise at BELITE BIO, INC involving 13796.000000 shares for an estimated $6050.93. Reported holdings after the transaction were 37259.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 24, 2026
- Filing date
- Oct 31, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
Filing warnings
Notes recorded with this filingBLTE price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code X
- Identifier
- 0001193125-26-442228 Ordinary Share
- Transaction date
- Sep 24, 2026 Filed Oct 31, 2026, 01:00 AM · 37d delay
- Shares
- 13,796 sh $0.44 per share
- Estimated value
- $6.05k Computed from shares × price
- Holdings after
- 37,259 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - delayed_filing-6 points
reporting_delay_days = 37
Filing delay exceeds the configured threshold.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
No footnotes recorded.
Original filing · 0001193125-26-4422280 other transactions
0 recent txs